Elicio Therapeutics Inc. Cash Flow Reinvestment Rate
Elicio Therapeutics Inc. cash flow reinvestment rate. Elicio Therapeutics Inc. (ELTX) has a Cash Flow Reinvestment Rate of 0.09x as of June 2022, reinvesting $559.00K (capex $559.00K ) from operating cash flow of $6.14 Million. Explore Elicio Therapeutics Inc. (ELTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Elicio Therapeutics Inc. (2012–2013)
Cash flow reinvestment rate of Elicio Therapeutics Inc. from 2012 to 2013. Historical reinvestment intensity for Elicio Therapeutics Inc. across 2 annual periods. Explore Elicio Therapeutics Inc. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Elicio Therapeutics Inc. Cash Flow Reinvestment Rate by Year (2012–2013)
Elicio Therapeutics Inc. cash flow reinvestment rate by year from 2012 to 2013. Year-by-year capital reinvestment analysis for Elicio Therapeutics Inc.. For the full cash flow conversion analysis, see ELTX cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.01x | $17.57K | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $47.73K | $1.07 Million | $47.73K | — |